Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
Go back to Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform| (AMEX: VSQTF) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $ | |||
| Open | $0.30 | 52 Week Low | $ | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $ | |||
| Volume | 2,490 | |||||
| (NYSE: VST) | Delayed: 157.11 +6.79 (4.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.32 | 52 Week High | $ | |||
| Open | $153.35 | 52 Week Low | $ | |||
| Day High | $158.74 | P/E | N/A | |||
| Day Low | $151.83 | EPS | $ | |||
| Volume | 3,507,389 | |||||



